mm

About Jason Novak

Jason has been a consistent contributor to VectorVest and has a blended interest in technology and finance, which he has written about for over a decade. When he's not demystifying complex financial topics or sharing a quick analysis of hot stocks on a given day, you may find him on the golf course or exploring all that Northern California has to offer.
5 10, 2022

Analyst Projects 90% Gain for Boeing Stock…Here are 3 Things He’s Missing

By |2023-12-07T21:11:15+00:00October 5th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , |

Companies situated in the travel industry have had a rough few years now as a result of the pandemic. And it’s not just airlines that are suffering - manufacturers like Boeing are feeling the effects themselves. Since the company’s stock experienced a 62% drop back in 2020, it struggled to regain its footing. This [...]

4 10, 2022

Twitter Stock Spikes as Musk Wants to Buy Twitter at Original Offer…What’s Your Next Move?

By |2023-12-07T21:11:15+00:00October 4th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , |

In the never-ending saga of Musk vs Twitter, it appears the eccentric billionaire is back with another proposal. This time? The original offer price of $54.20/share. Down below, we’ll highlight the details of what we know so far and what you should do from an investment standpoint. This deal leads to a valuation of [...]

3 10, 2022

Viasat’s Deal Repositions to Compete with SpaceX – But is This Reason Enough to Buy VSAT Stock Now?

By |2023-12-07T21:11:15+00:00October 3rd, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , |

Viasat, a satellite broadband communications company for the military and commercial markets, enjoyed a 40% boost in stock price Monday morning. This spike resulted from their deal with defense contractor L3 Harris Technologies. In total, the deal is estimated to bring in over $1.8 billion after taxes, fees, and other expenses. The deal will [...]

30 09, 2022

Nike Stock Falls as Margins Drop & Inventory Grows…Should You Weather the Storm or Sell Now?

By |2023-12-07T21:11:16+00:00September 30th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , |

Nike stock plunged 12% this morning after another earnings report that missed expectations. While revenue and EPS figures came in strong, the margins slipped up a bit - which has only been exacerbated by inflation. But the real reason analysts and investors alike have growing concern over the trajectory of Nike? Inventory. Their inventory [...]

29 09, 2022

A Dwindling Pandemic Spells Disaster for Rite Aid Stock…could it get even worse?

By |2023-12-07T21:11:16+00:00September 29th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , |

While Rite Aid had a good run during the pandemic, it appears the stock is headed back towards the bottom - as the company reports another quarter of poor results. The retail drug store chain lost over $300 million in the fiscal 2nd quarter. This resulted in a net loss per share of $6.07, [...]

29 09, 2022

Cheniere Energy Powers Ahead in the Liquefied Natural Gas Market

By |2023-12-07T21:11:16+00:00September 29th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

On Thursday, September 28, LNG had a huge up day with a $10.60 gain (6.95%) after hitting an intraday low of $147.70 on September 26.  The high for the year was on September 14 at $178.62.  The closing price pierced its 50-day moving average and closed well above it. Over the past year, energy-related [...]

28 09, 2022

What Biogen’s Alzheimer’s Drug Results Means for the Company’s Stock

By |2023-12-07T21:11:17+00:00September 28th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , |

Yesterday, we discussed how Crispr stock enjoyed a short-lived jump ahead of seeking FDA approval for their gene therapy drug. But today, we’re here to talk about a drug company that has experienced a much larger spike as a result of positive news: Biogen. Biogen is engaged in discovering, developing, and delivering therapies for [...]

27 09, 2022

Crispr Stock Jumps after Seeking FDA Approval for Gene Therapy Drug…Should You Buy Now?

By |2023-12-07T21:11:17+00:00September 27th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , |

While many stocks are moving downwards this morning, one stock has made a nice 5% jump since the market opened - and that’s Crispr.  The company is engaged in the development of transformative drugs based on gene therapy. And news just released that they are finally on the path to seeking FDA approval for [...]

26 09, 2022

What Amazon Announcing Second Prime Day Sale Means for Investors!!

By |2023-12-07T21:11:17+00:00September 26th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , |

It was announced early this morning that Amazon is adding another Prime Day sale to their calendar. Prime Day has historically come once a year and has been the most lucrative day for the company - and its sellers. Revenue on Prime Day has even surpassed Black Friday/Cyber Monday sales in the past. This [...]

23 09, 2022

LLY is Upgraded by Analysts Ahead of New Drug…But What Does VectorVest Rate the Stock?

By |2023-12-07T21:16:13+00:00September 23rd, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , |

You’d be hard-pressed to find a stock that’s shown positive growth over the past year - but Eli Lilly is one of them. The pharmaceutical developer & manufacturer has had a great year - up 35% in the last 365 days. Even looking at the bigger picture, this stock has been a high-performer. This [...]

Go to Top